Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) in Norway
Norway: Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) was 96.0% in 2025. ◆ Volatile
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) in Norway, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, hepatitis b (hepb3) immunization coverage among 1-year-olds (%) in Norway stood at 96.0%.
That represents a change of down 1.0% over five years.
Over the whole period, hepatitis b (hepb3) immunization coverage among 1-year-olds (%) in Norway peaked at 97.0% in 2020 and was at its lowest, 0.0%, in 2000.
That places Norway 40th out of 194 countries with data for 2025, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) in Norway, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 96.0% | — |
| 2020 | 97.0% | +1.0% |
| 2021 | 96.0% | -1.0% |
| 2022 | 96.0% | +0.0% |
| 2023 | 96.0% | +0.0% |
| 2024 | 96.0% | +0.0% |
| 2025 | 96.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 9.6% | 0.0% | 96.0% | 10 |
| 2020s | 96.2% | 96.0% | 97.0% | 6 |
Countries ranked near Norway
- 40 France 96.0% compare
- 40 Sri Lanka 96.0% compare
- 40 Albania 96.0% compare
- 40 Mauritius 96.0% compare
- 40 Qatar 96.0% compare
- 40 Eritrea 96.0% compare
- 40 Uruguay 96.0% compare
- 40 Israel 96.0% compare
- 40 Mongolia 96.0% compare
- 40 Morocco 96.0% compare
- 40 Slovakia 96.0% compare
- 40 Singapore 96.0% compare
- 40 Palau 96.0% compare
- 40 Nepal 96.0% compare
- 40 Costa Rica 96.0% compare
- 40 Nicaragua 96.0% compare
- 40 China 96.0% compare
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Heat deaths vs projected death rates 1,212 (2090)
- Un projection of annual infant deaths 12 (2100)
- Population ages 0-14, female, annual growth rate -0.9506 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0775 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.9586 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0817 units per person (2025)
Frequently asked questions
- What is hepatitis b (hepb3) immunization coverage among 1-year-olds (%) in Norway?
- Hepatitis b (hepb3) immunization coverage among 1-year-olds (%) in Norway was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b (hepb3) immunization coverage among 1-year-olds (%) recorded in Norway?
- The highest recorded value was 97.0% in 2020.
- What is the lowest hepatitis b (hepb3) immunization coverage among 1-year-olds (%) recorded in Norway?
- The lowest recorded value was 0.0% in 2000.
- How does Norway rank for hepatitis b (hepb3) immunization coverage among 1-year-olds (%)?
- Norway ranks 40th out of 194 countries with data for 2025.
- Where does this Norway data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).